ArticleSurgical neurology international2025
Incidence and clinicopathological features of meningioma at the National Brain Center Hospital in Indonesia.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Survival Outcomes and Prognostic Factors in Patients with Meningioma: A Single-Center Study at the Indonesian National Cancer Center Dharmais Hospital (2019-2025).Current oncology (Toronto, Ont.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Meningioma is considered a high-prevalence disease, accounting for eight cases per 100,000 population, among intracranial tumors. This study aimed to assess the epidemiological and clinicopathological features of meningioma patients. Methods: This retrospective cohort study included hospitalized meningioma patients (excluding spinal meningioma) at the National Brain Hospital, Jakarta, Indonesia, between 2020 and 2022. Patient characteristics, symptoms, and magnetic resonance imaging results before and after surgery were obtained from medical records. Chi-square test, Fisher's exact test, and logistic regression analysis performed with Results: A total of 325 patients were analyzed between 2020 and 2022, with the number of patients increasing annually. Grade I meningiomas were more prevalent than Grades II and III. However, patients with Grades II and III were slightly older than those with Grade I (mean age 47.6 ± 13.7 years and 46.9 ± 10.3 years, respectively). Most patients were women, with a women to men ratio of 4:1. The most common sites of brain meningiomas were the convexity (26.8%), parasellar region (11.7%), and falx (34%). Hearing impairment was the sole clinical symptom that was significantly associated with meningioma grading, with an adjusted odds ratio of 0.313 (95% confidence interval : 0.113-0.869, Conclusion: In Indonesia, the number of meningioma cases has been increasing steadily from 2020 to 2022, and women are at risk of developing meningioma. The presence of hearing impairment is associated with low-grade meningioma; however, further research is needed to confirm this finding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.